Gilead CEO Dan O'Day (AP Images)
Is Gilead chief Dan O’Day ready for a new biotech deal in the oncology field?
Twitter lit up Wednesday afternoon after Bloomberg put out a story that a deal-hungry Gilead was in the hunt to buy a stake in Arcus …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
